Abdominal wall mucormycosis successfully treated with amphotericin and itraconazole.
The routine management of cutaneous mucormycosis consists of combined surgical and medical therapy. We present a case of successful medical therapy with sequential liposomal amphotericin B and itraconazole for a peri-ostomal cutaneous Rhizopus infection in a 59-year-old woman following treatment for pyoderma gangrenosum in the setting of inflammatory bowel disease.
Hunter
Alan J
AJ
Department of Medicine, Oregon Health Sciences University, Portland, OR 97201, USA. huntera@ohsu.edu
Bryant
Richard E
RE
D000009:Abdominal Muscles / Q000473:pathology*; D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications / Q000188:drug therapy; D017964:Itraconazole / Q000627:therapeutic use*; D008875:Middle Aged; D009091:Mucormycosis / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology*; D010713:Phosphatidylcholines / Q000627:therapeutic use*; D010715:Phosphatidylglycerols / Q000627:therapeutic use*; D017511:Pyoderma Gangrenosum / Q000150:complications / Q000188:drug therapy; D012233:Rhizopus / Q000302:isolation & purification
D000935:Antifungal Agents; D004338:Drug Combinations; D010713:Phosphatidylcholines; D010715:Phosphatidylglycerols; C068538:liposomal amphotericin B; D017964:Itraconazole; D000666:Amphotericin B